Vitamin D receptor ligands, adenomatous polyposis coli, and the vitamin D receptor Fok I polymorphism collectively modulate β‐catenin activity in colon cancer cells
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
The activity of β‐catenin, commonly dysregulated in human colon cancers, is inhibited by the vitamin D receptor (VDR), and this mechanism is postulated to explain the putative anti‐cancer activity of vitamin D metabolites in the colon. We investigated the effect of a common Fok I restriction site polymorphism (F/f) in the human VDR gene as well as the effect of anti‐tumorigenic 1,25‐dihydroxyvitamin D 3 (1,25D) and pro‐tumorigenic lithocholic acid (LCA) VDR ligands on β‐catenin transcriptional activity. Furthermore, the influence of a major regulatory protein of β‐catenin, the APC tumor suppressor gene, on VDR‐dependent inhibition of β‐catenin activity was examined. We report herein that β‐catenin‐mediated transcription is most effectively suppressed by the VDR Fok I variant F/M4 when 1,25D is limiting. Using Caco‐2 colorectal cancer (CRC) cells, it was observed that VDR ligands, 1,25D and LCA, both suppress β‐catenin transcriptional activity, though 1,25D exhibited significantly greater inhibition. Moreover, 1,25D, but not LCA, suppressed endogenous expression of the β‐catenin target gene DKK‐4 independent of VDR DNA‐binding activity. These results support β‐catenin sequestration away from endogenous gene targets by 1,25D–VDR. This activity is most efficiently mediated by the Fok I gene variant F/M4, a VDR allele previously associated with protection against CRC. Interestingly, we found the inhibition of β‐catenin activity by 1,25D–VDR was significantly enhanced by wild‐type APC. These results reveal a previously unrecognized role for 1,25D–VDR in APC/β‐catenin cross talk. Collectively, these findings strengthen evidence favoring a direct effect on the Wnt‐signaling molecule β‐catenin as one anti‐cancer target of 1,25D–VDR action in the colorectum. © 2009 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The β-Catenin/TCF-4 Complex Imposes a Crypt Progenitor Phenotype on Colorectal Cancer Cells
van de Wetering, M., Sancho, E., Verweij, C., de Lau, W., Oving, I., Hurlstone, A., van der Horn, K., Batlle, E., Coudreuse, D., Haramis, A.-P., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)01014-0 · Cited by 2,030
Vitamin D Receptor As an Intestinal Bile Acid Sensor
Makishima, M., Lu, T. T., Xie, W., Whitfield, G. K., Domoto, H., Evans, R. M., Haussler, M. R., & Mangelsdorf, D. J. (2002) · Science · doi:10.1126/science.1070477 · Cited by 1,176
Self-citationAPC, Signal transduction and genetic instability in colorectal cancer
Fodde, R., Smits, R., & Clevers, H. (2001) · Nature Reviews Cancer · doi:10.1038/35094067 · Cited by 937 · cited 4×
“Cytoplasmic levels of b-catenin are regulated by a degradative complex composed of axin, adenomatous polyposis coli (APC) tumor suppressor, and GSK3-b which phosphorylates b-catenin for ubiquitination and degradation by the proteasome [24,26].”
BackgroundInfluentialThe Roles of APC and Axin Derived from Experimental and Theoretical Analysis of the Wnt Pathway
Lee, E., Salic, A., Krüger, R., Heinrich, R., & Kirschner, M. W. (2003) · PLoS Biology · doi:10.1371/journal.pbio.0000010 · Cited by 708
Cited by
Molecular Mechanisms of Vitamin D Action
Haussler, M. R., Whitfield, G. K., Kaneko, I., Haussler, C. A., Hsieh, D., Hsieh, J.-C., & Jurutka, P. W. (2013) · Calcified Tissue International · doi:10.1007/s00223-012-9619-0 · Cited by 759
“Finally, 1,25D has been shown to suppress b-catenin signaling in colon cancer cells [80], and b-catenin is a proto-oncogene that participates in the growthpromoting Wnt signaling pathway that is thought to play a significant role in the etiology of colon cancer.”
BackgroundSelf-citationHaussler, M. R., Jurutka, P. W., Mizwicki, M., & Norman, A. W. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.010 · Cited by 683
Self-citationVitamin D and cancer: a review of molecular mechanisms
Fleet, J. C., Desmet, M., Johnson, R., & Li, Y. (2012) · Biochemical Journal · doi:10.1042/bj20110744 · Cited by 407
Pereira, F., Barbáchano, A., Silva, J., Bonilla, F., Campbell, M. J., Muñoz, A., & Larriba, M. J. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr399 · Cited by 177
Role of the RANK/RANKL/OPG and Wnt/β-Catenin Systems in CKD Bone and Cardiovascular Disorders
Workgroup, O. B. O. T. E. R. O. (., Carrillo-López, N., Martínez-Arias, L., Fernández-Villabrille, S., Ruiz-Torres, M. P., Dusso, A., Cannata-Andía, J. B., Naves-Díaz, M., & Panizo, S. (2021) · Calcified Tissue International · doi:10.1007/s00223-020-00803-2 · Cited by 91
Metadata
- Authors
- Egan, J. B., Thompson, P. A., Vitanov, M. V., Bartik, L., Jacobs, E. T., Haussler, M. R., Gerner, E. W., & Jurutka, P. W.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2009-12-30
- Volume
- 49
- Issue
- 4
- Pages
- 337-352
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2129555025
- Cited by
- 74
- References
- 4
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.